Delhi High Court Protects Domino's Trademark Against Infringement Injunction Against Similar Names: The Delhi High Court ordered to stop restaurants from using names like "Dominic Pizza" and "Domindo Pizza" because they were too similar to Domino's. Likelihood of Customer Confusion: Domino's argued, and the court agreed, that these names were likely to mislead customers into thinking they were associated with Domino's. Trademark Infringement: The court found that using these similar names violated Section 29 of the Trade Marks Act, 1999, which protects registered trademarks. De-listing from Platforms: The court ordered Swiggy and Zomato to remove these restaurants from their online platforms. Protection of Well-Known Trademarks: The court emphasized the importance of protecting established and well-known trademarks from being weakened or infringed upon. #trademark #intellectualproperty #infringement #Oohripr #Dominos Website:myoohripr.com
Oohr Intellectual Research LLP
法律服务
Technical Consultation in all IPR related queries, Help to grow technology and protect IP
关于我们
We specialized in intellectual property and technology domain expertise. Our team of experts is highly experienced in patent law, intellectual property law, and technology field. We have a deep understanding of the complexities of intellectual property and technology domain, and we are committed to providing our clients with the best possible advice and guidance. We have a wide range of experience in patent prosecution, patent litigation, and patent licensing. We also provide services related to trademark registration, copyright registration, and trade secret protection.
- 网站
-
https://www.myoohripr.com/
Oohr Intellectual Research LLP的外部链接
- 所属行业
- 法律服务
- 规模
- 51-200 人
- 总部
- CA
- 类型
- 私人持股
- 创立
- 2013
- 领域
- Patent consulting、patent infringement, 、 freedom to operate, FTO, patent invalidity,、patent litigation、Provisional Application drafting、Prior Art searches、Intellectual Property Research和technology field
地点
-
主要
获取路线
US，CA
Oohr Intellectual Research LLP员工
-
Mukul Pant
???????????????????????? | Founder - ???????? (??????????????????????/????/????/??????) | ?????????? (??????????????????????.????) | | ????????????…
-
Dr. Mike Oohr
Founder | Oohr Intellectual Research LLP
-
Ishfaq khan
Chief business development executive | Oohr innovations | Oohr intellectual research
-
Khalid Fayaz
Web Developer at Oohr Innovations | Data Engineer at Oohr Intellectual Research LLP
动态
-
“Wishing you a shamrockin’ good time this St. Patrick’s Day!” #wishing #patrickday #Oohripr #Happy Website:myoohripr.com
-
May this Holi bring you vibrant colors of joy, love, and prosperity! ... #holi #colors #joy #love #Oohripr #prosperity Website:myoohripr.com
-
Exploring the Universe’s Mysteries: The Large Hadron Collider (LHC) #ParticlePhysics #Innovation #HiggsBoson #IntellectualProperty #OohrIntellectualResearchLLP Website:myoohripr.com
-
The ReAnima Project: Exploring the Ethics of AI Consciousness #AI #Ethics #Innovation #IntellectualProperty #ReAnimaProject #OohrIntellectualResearchLLP #Oohripr Website:myoohripr.com
-
Patent Grant: Innocan Pharma has been granted a patent in India. This signifies official recognition and legal protection of their invention. Invention: The patent covers a liposomal Cannabidiol (CBD) injection. This is a specific formulation and delivery method for CBD. Liposomal Delivery: The use of liposomes is a key aspect. Liposomes are tiny spherical structures that can encapsulate drugs (in this case, CBD) and improve their delivery to the target site in the body. This often translates to increased bioavailability, meaning the body can absorb and utilize the CBD more effectively. Territorial Protection: The patent specifically applies in India. This gives Innocan exclusive rights to market and sell this particular liposomal CBD injection in the Indian market. Potential Therapeutic Applications: While the news doesn't specify the exact conditions, liposomal CBD injections could potentially be used to treat various conditions where CBD has shown promise. This might include areas like pain management, inflammation, anxiety, or neurological disorders. Further research and clinical trials would be needed to establish specific uses. Market Advantage: The patent provides Innocan with a competitive advantage in the Indian pharmaceutical market. It gives them exclusivity, preventing others from producing and selling the same liposomal CBD injection. Pharmaceutical Innovation: This patent highlights innovation in drug delivery systems for CBD. It suggests Innocan is investing in research and development to create more effective and targeted CBD-based therapies. Future Commercialization: The patent is a crucial step towards commercialization. It paves the way for Innocan to potentially develop and launch their liposomal CBD injection product in India. Potential for Further Research: The patent could also lead to further research and development, exploring the optimal use of this liposomal CBD formulation for various medical conditions. #patent #intellectualproperty #medical #india #Oohripr Website:myoohripr.com
-
-
"We are grateful for your service and the upliftment of our country" #Presidentday #Country #service #grateful #Oohripr Website:myoohripr.com
-
-
The Human Connectome Project: Unlocking the Secrets of the Human Brain #humanbrain #Oohripr #ipr #connectome Website:myoohripr.com